inflammation

Showing NaN - NaN of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))

Recruiting
  • Cardiovascular Risk
  • +2 more
  • Birmingham, Alabama
  • +768 more
Dec 23, 2022

Inflammation, HPA, CBCL Trial in New York, São Paulo (Supplemental cash transfer)

Recruiting
  • Inflammation
  • +3 more
  • Supplemental cash transfer
  • New York, New York
  • +1 more
Jul 26, 2022

Memory Loss, Inflammation Trial in New York (650 mg of Cocoapro flavanols, 0 mg of Cocoapro flavanols)

Recruiting
  • Memory Loss
  • Inflammation
  • 650 mg of Cocoapro flavanols
  • 0 mg of Cocoapro flavanols
  • New York, New York
    Columbia University Medical Center
Jul 1, 2022

Preterm Birth, Inflammation, Stress Trial in New York (Cognitive Challenge)

Recruiting
  • Preterm Birth
  • +3 more
  • Cognitive Challenge
  • New York, New York
    Columbia University Irving Medical Center
Apr 26, 2022

Coronary Artery Disease, Inflammation Trial in New York (Diet)

Completed
  • Coronary Artery Disease
  • Inflammation
  • Diet
  • New York, New York
    NYUMC Tisch Hospital, HCC 14
Apr 23, 2018

Biologic Materials From Mediastinal Lymph Nodes From Lung

Terminated
  • Lung Disease
  • +3 more
    • New York, New York
      Weill Cornell Medical College and Weill Cornell Medical Center,
    Dec 21, 2017

    Spinal Stenosis, Inflammation Trial in New York (Dexmedetomidine group, Placebo group)

    Terminated
    • Spinal Stenosis
    • Inflammation
    • Dexmedetomidine group
    • Placebo group
    • New York, New York
    • +1 more
    Jun 9, 2017

    Hip Fracture, Myocardial Ischemia, Inflammation Trial in New York (Atorvastatin, Placebo)

    Completed
    • Hip Fracture
    • +2 more
    • New York, New York
    • +1 more
    Jun 2, 2017

    Inflammation, Psoriasis Trial in United States (anti-IL-20, )

    Terminated
    • Inflammation
    • Psoriasis
    • Birmingham, Alabama
    • +15 more
    Feb 8, 2017

    Inflammation, Crohn's Disease Trial in Worldwide (NNC 0142-0000-0002, Placebo)

    Completed
    • Inflammation
    • Crohn's Disease
    • NNC 0142-0000-0002
    • Placebo
    • Anaheim, California
    • +22 more
    Jul 29, 2016

    Postoperative Pain, Inflammation Trial in New York (Choline, Placebo)

    Terminated
    • Postoperative Pain
    • Inflammation
    • New York, New York
      New York Presbyterian Hospital
    Mar 23, 2016

    Coronary Heart Disease Incidence: Depression & Inflammation Risk

    Completed
    • Cardiovascular Diseases
    • +4 more
      • New York, New York
        Columbia University
      Feb 4, 2016

      Inflammation in Type 2 Myocardial Infarction

      Withdrawn
      • Myocardial Infarction
      • +2 more
        • New York, New York
          Bellevue Hospital Center
        Jul 1, 2015